You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Litigation Details for Salix Pharmaceuticals Inc. v. Novel Laboratories Inc. (D. Del. 2015)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Salix Pharmaceuticals Inc. v. Novel Laboratories Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .

Details for Salix Pharmaceuticals Inc. v. Novel Laboratories Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-01-07 1 United States Patent Numbers 6,551,620 (“the ’620 patent”), 8,337,886 (“the ’886 patent”), 8,496,965 …Bases for NOVEL’S Certification That U.S. Patent Nos. 6,551,620 B2, 8,337,886 B2, and 8,496,965 B2 are …’965 patent”), and 8,865,688 (“the ’688 patent”) (collectively, “the Orange Book-listed patents”). …is an action for patent infringement arising under the food and drug laws and patent laws of the United… THE PATENT IN SUIT 12. Falk is the owner by assignment of the ’688 patent, entitled External link to document
2015-01-07 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) us 8,865,688;. (mas) (Entered:…2015 31 July 2017 1:15-cv-00027 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.